Sandipkumar S. Kapadia
Director of Finance/CFO at HARMONY BIOSCIENCES HOLDINGS, INC.
Net worth: 234 623 $ as of 2024-03-30
Profile
Sandipkumar S.
Kapadia is currently serving as an Independent Director at Molecular Partners AG since 2020.
He is also an Independent Non-Executive Director at Passage Bio, Inc. since 2019.
Additionally, he holds the position of Director at Intercept Pharma Europe Ltd.
and Molecular Partners, Inc. Furthermore, he is a Director at VectivBio AG since 2020 and the Chief Financial & Administrative Officer at Harmony Biosciences Holdings, Inc. since 2021.
He is also a Member-Supervisory Board at Therachon Holding GmbH.
In his former roles, Mr. Kapadia served as a Director at Intercept Pharma UK & Ireland Ltd.
from 2017 to 2021.
He was also a Co-Managing Director at Intercept Pharma Deutschland GmbH.
Moreover, he held the position of Director at Therachon AG.
He served as an Independent Director at VectivBio Holding AG from 2020 to 2023.
Prior to that, he was the Chief Financial Officer & Vice President at Sandoz, Inc. from 2014 to 2016.
He also served as the Chief Financial Officer & Treasurer at Intercept Pharmaceuticals, Inc. from 2016 to 2021.
He held the position of Chief Financial Officer & Vice President at Novartis Pharmaceuticals UK Ltd.
from 2009 to 2012.
Additionally, he served as the Head-Finance at Novartis Pharmaceuticals Corp.
and Novartis Pharmaceuticals AG.
He was also the Chief Financial Officer & Vice President at Novartis Pharmaceuticals BV from 2009 to 2012.
Mr. Kapadia completed his MBA from Rutgers State University of New Jersey.
He also holds an undergraduate degree from Montclair State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-28 | 6,987 ( 0.01% ) | 234 623 $ | 2024-03-30 | |
PASSAGE BIO, INC.
-.--% | 2023-05-24 | 0 ( -.--% ) | - $ | 2024-03-30 |
Sandipkumar S. Kapadia active positions
| Companies | Position | Start |
|---|---|---|
| PASSAGE BIO, INC. | Director/Board Member | 2019-11-30 |
| MOLECULAR PARTNERS AG | Director/Board Member | 2020-03-31 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director of Finance/CFO | 2021-03-28 |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Director/Board Member | - |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Director/Board Member | 2020-12-14 |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK. | Director/Board Member | 2016-09-27 |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Director/Board Member | - |
Former positions of Sandipkumar S. Kapadia
| Companies | Position | End |
|---|---|---|
| VECTIVBIO HOLDING AG | Director/Board Member | 2023-06-25 |
| INTERCEPT PHARMACEUTICALS, INC. | Director of Finance/CFO | 2021-03-25 |
| ░░░░░░░░░ ░░░░░░ ░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Sandipkumar S. Kapadia
| Rutgers State University of New Jersey | Masters Business Admin |
| Montclair State University | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| MOLECULAR PARTNERS AG | Health Technology |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| Private companies | 13 |
|---|---|
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Novartis Pharmaceuticals AG | |
Novartis Pharmaceuticals BV
 Novartis Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals BV is a Dutch company that manufactures pharmaceutical products. The private company is based in Arnhem, Netherlands. | Health Technology |
Therachon Holding GmbH
Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland. | Health Technology |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK. | Commercial Services |
Intercept Pharma UK & Ireland Ltd.
 Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the private company is based in Bristol, UK. | Distribution Services |
Intercept Pharma Deutschland GmbH
 Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The private company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | Distribution Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
| Therachon AG | |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Sandipkumar S. Kapadia
